MetLife, Inc.
MET
$97.66
$0.190.20%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 78.45B | 76.73B | 75.97B | 71.43B | 71.03B |
| Total Other Revenue | 952.00M | 856.00M | 1.12B | 507.00M | 1.98B |
| Total Revenue | 79.40B | 77.59B | 77.08B | 71.94B | 73.01B |
| Cost of Revenue | 60.38B | 59.15B | 59.07B | 54.48B | 54.23B |
| Gross Profit | 19.02B | 18.43B | 18.01B | 17.45B | 18.79B |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 13.74B | 13.24B | 12.80B | 12.48B | 12.25B |
| Total Operating Expenses | 74.12B | 72.39B | 71.87B | 66.96B | 66.48B |
| Operating Income | 5.28B | 5.19B | 5.21B | 4.98B | 6.54B |
| Income Before Tax | 4.87B | 4.81B | 4.66B | 4.93B | 5.71B |
| Income Tax Expenses | 1.21B | 1.20B | 1.26B | 1.06B | 1.41B |
| Earnings from Continuing Operations | 3.66K | 3.62K | 3.40K | 3.86K | 4.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -33.00M | 4.00M | -24.00M | -21.00M | -14.00M |
| Net Income | 3.63B | 3.62B | 3.38B | 3.84B | 4.29B |
| EBIT | 5.28B | 5.19B | 5.21B | 4.98B | 6.54B |
| EBITDA | 6.04B | 5.95B | 5.97B | 5.69B | 7.25B |
| EPS Basic | 5.26 | 5.20 | 4.74 | 5.35 | 5.94 |
| Normalized Basic EPS | 4.60 | 4.56 | 4.32 | 4.51 | 5.16 |
| EPS Diluted | 5.22 | 5.16 | 4.70 | 5.31 | 5.90 |
| Normalized Diluted EPS | 4.57 | 4.54 | 4.29 | 4.48 | 5.13 |
| Average Basic Shares Outstanding | 2.62B | 2.65B | 2.68B | 2.71B | 2.75B |
| Average Diluted Shares Outstanding | 2.63B | 2.66B | 2.69B | 2.73B | 2.76B |
| Dividend Per Share | 2.30 | 2.27 | 2.25 | 2.23 | 2.20 |
| Payout Ratio | 46.36% | 46.42% | 50.40% | 44.44% | 39.96% |